RSS-Feed abonnieren
DOI: 10.1055/a-2490-1091
Intercostal Nerve Cryoablation as an Effective Pain Management Strategy in the Nuss Procedure: Reducing Opioid Use and Hospital Stay
Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Abstract
Introduction Erector spinae plane (ESP) blocks, thoracic epidural, and patient-controlled analgesia (PCA) have all been used for perioperative pain management in the Nuss procedure without a consensus on what modality produces the best outcomes. Intercostal nerve cryoablation (INC) is a relatively new modality that involves freezing the nerves to prevent pain during recovery. Our hypothesis is that using INC for the Nuss procedure will decrease opioid use, pain scores, and length of stay (LOS) but will increase cost compared with ESP block, thoracic epidural, and PCA.
Materials and Methods This retrospective, observational study compared 108 patients who underwent the Nuss procedure at a pediatric acute care children's hospital in the southeast US. Patient charts were evaluated for significant differences in LOS, opioid use, and reported pain ratings based on type of analgesia administered: INC (n = 30), ESP block (n = 19), thoracic epidural (n = 41), and PCA (n = 18). Secondary variables included emergency department visits, readmissions, opioid refills, and various anesthetic and operative costs. Analysis of variance was performed on all outcome measures.
Results Average LOS was significantly decreased in the INC group (2.9 days) compared with the thoracic epidural (4.7 days, p < 0.05) and the PCA groups (3.7 days, p < 0.05). Average cumulative opioid use was significantly decreased in the INC group (50.4 morphine milligram equivalents [MME]) compared with the thoracic epidural (117 MME, p < 0.05) and PCA groups (172.1 MME, p < 0.05).
Conclusions This study suggests that INC can be a viable and cost-effective option for reducing postoperative opioid consumption and LOS in Nuss procedure patients. Pain perception was lower in the INC group compared with the rest of the groups, except the epidurals, which were similar. However, the opioid consumption of the INC group was significantly lower than any other group. Despite the INC group having higher initial costs, it did not result in the highest total hospital charges, indicating its potential cost-effectiveness. There is a need for larger prospective randomized controlled trials to guide future research efforts.
Publikationsverlauf
Eingereicht: 01. Februar 2024
Angenommen: 24. November 2024
Artikel online veröffentlicht:
19. Dezember 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 de Oliveira Carvalho PE, da Silva MVM, Rodrigues OR, Cataneo AJM. Surgical interventions for treating pectus excavatum. Cochrane Database Syst Rev 2014; 2014 (10) CD008889
- 2 Abid I, Ewais MM, Marranca J, Jaroszewski DE. Pectus excavatum: a review of diagnosis and current treatment options. J Am Osteopath Assoc 2017; 117 (02) 106-113
- 3 Nuss D, Obermeyer RJ, Kelly RE. Nuss bar procedure: past, present and future. Ann Cardiothorac Surg 2016; 5 (05) 422-433
- 4 Papic JC, Finnell SME, Howenstein AM, Breckler F, Leys CM. Postoperative opioid analgesic use after Nuss versus Ravitch pectus excavatum repair. J Pediatr Surg 2014; 49 (06) 919-923 , discussion 923
- 5 Weber T, Mätzl J, Rokitansky A, Klimscha W, Neumann K, Deusch E. Medical Research Society. Superior postoperative pain relief with thoracic epidural analgesia versus intravenous patient-controlled analgesia after minimally invasive pectus excavatum repair. J Thorac Cardiovasc Surg 2007; 134 (04) 865-870
- 6 Mavi J, Moore DL. Anesthesia and analgesia for pectus excavatum surgery. Anesthesiol Clin 2014; 32 (01) 175-184
- 7 Muhly WT, Maxwell LG, Cravero JP. Pain management following the Nuss procedure: a survey of practice and review. Acta Anaesthesiol Scand 2014; 58 (09) 1134-1139
- 8 Singhal NR, Jerman JD. A review of anesthetic considerations and postoperative pain control after the Nuss procedure. Semin Pediatr Surg 2018; 27 (03) 156-160
- 9 Evans PJ. Cryoanalgesia: the application of the low temperatures to nerves to produce anesthesia or analgesia. Anaesthesia 1981; 36 (11) 1103-1113
- 10 Velayos M, Alonso M, Delgado-Miguel C. et al. Percutaneous cryoanalgesia: a new strategy for pain management in pectus excavatum surgery. Eur J Pediatr Surg 2022; 32 (01) 73-79
- 11 Aiken TJ, Stahl CC, Lemaster D. et al. Intercostal nerve cryoablation is associated with lower hospital cost during minimally invasive Nuss procedure for pectus excavatum. J Pediatr Surg 2021; 56 (10) 1841-1845
- 12 Graves CE, Moyer J, Zobel MJ. et al. Intraoperative intercostal nerve cryoablation during the Nuss procedure reduces length of stay and opioid requirement: a randomized clinical trial. J Pediatr Surg 2019; 54 (11) 2250-2256
- 13 Keller BA, Kabagambe SK, Becker JC. et al. Intercostal nerve cryoablation versus thoracic epidural catheters for postoperative analgesia following pectus excavatum repair: preliminary outcomes in twenty-six cryoablation patients. J Pediatr Surg 2016; 51 (12) 2033-2038
- 14 Rettig RL, Rudikoff AG, Lo HYA. et al. Cryoablation is associated with shorter length of stay and reduced opioid use in pectus excavatum repair. Pediatr Surg Int 2021; 37 (01) 67-75
- 15 Santana L, Driggers J, Carvalho NF. Pain management for the Nuss procedure: comparison between erector spinae plane block, thoracic epidural, and control. World J Pediatr Surg 2022; 5 (04) e000418
- 16 Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The erector spinae plane block: a novel analgesic technique in thoracic neuropathic pain. Reg Anesth Pain Med 2016; 41 (05) 621-627
- 17 Hamilton DL. Pneumothorax following erector spinae plane block. J Clin Anesth 2019; 52: 17
- 18 Lai K, Eldredge RS, Zobel M, Hargis-Villanueva A, Ostlie A, Padilla BE. Intercostal nerve cryoablation for postoperative pain control in pediatric thoracic surgery: a scoping review. J Laparoendosc Adv Surg Tech A 2023; 33 (10) 994-1004